Home / Private raises / QuantBio LP
QuantBio LP
Hedge Fund · New York, New York · $36.4M sold across 1 offering
Form D filings (1)
| Filed | Form | Sold | Offered | Investors | Exemption | Securities | First sale | |
|---|---|---|---|---|---|---|---|---|
| 2026-09-25 | D/A (update) | $36.4M | Open-ended | 30 | 506(b), 3(c), 3(c)(7) | Fund interests | Apr 1 | SEC ↗ |
An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.
Sold through (placement agents)
| Broker-dealer | Solicited in |
|---|---|
| GALLATIN CAPITAL LLC | All States |
No sales commission reported in the latest filing.
Issuer
| Industry | Pooled Investment Fund |
| Fund type | Hedge Fund |
| Located | New York, New York |
| Entity | Limited Partnership |
| Incorporated | Delaware, 2023 |
| SEC CIK | 2012935 |
People named in the latest filing
| Name | Role |
|---|---|
| JEAN-PIERRE NAEGELI | Executive Officer |
| ANDREW RUBINSTEIN | Executive Officer |
Names and roles as filed with the SEC. Addresses are not shown.
Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.
How are we doing?
